• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • NMPA Publishes 6 Regulatory Drafts Concerning Clinical Trials for Medical Devices and IVDs

NMPA Publishes 6 Regulatory Drafts Concerning Clinical Trials for Medical Devices and IVDs

Thursday, 27 May 2021 / Published in Medical Device, News, NMPA Registration in China

NMPA Publishes 6 Regulatory Drafts Concerning Clinical Trials for Medical Devices and IVDs

On May 10, 2021, the NMPA (National Medical Products Administration) published 6 regulatory draft documents concerning clinical trials for medical devices and IVDs:

  • Medical device clinical trial protocol template (Draft)
  • Medical device clinical trial report template (Draft)
  • In vitro diagnostic reagent clinical trial protocol template (Draft)
  • In vitro diagnostic reagent clinical trial report template (Draft)
  • Sample report form for serious adverse events in clinical trials of medical devices/in vitro diagnostic reagents (Draft)
  • Basic catalogue documents for clinical trials of medical devices (Draft)

The NMPA is currently soliciting public comments on the draft documents. The public consultation period is open until May 30, 2021.

Highlights

  • Covers the unified clinical trial test protocols and report format of IVD reagents
  • Heavily focuses on the procedures and requirements for reporting adverse events during clinical trials
  • Formulate a standardized directory using the data traceability of clinical trials
  • Identify items for improvements and blind spots from previous clinical trials, and propose actions to improve

By Jacky Li and Colleen Xu. Contact Cisema if you would like to learn more.

Tagged under: Clinical Trials, IVDs

What you can read next

Clinical Trial Guidelines Updated & Various Draft Product Guidelines Issued
China special equipment safety supervision
China special equipment safety supervision – draft provisions released
GB 16897 Test standard for brake hoses and tubing for motor vehicles, motorcycles and trailers – Implementation of new revision expected in July 2023

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Submission of safety information for cosmetics ingredients

    Submission of safety information for cosmetics raw materials – Draft guidelines issued

    Submission of safety information for cosmetics ...
  • avoid animal testing in Chinaweb-2023

    How to avoid animal testing in China for cosmetics | Cisema Webinar

    China’s beauty and cosmetic market has be...
  • guidelines for medical devices registration

    Guidelines for medical devices registration in China – New development plans in 2023

    Guidelines for medical devices registration in ...
  • China DMF of API

    China DMF of API, Excipient & Packaging Materials: Market & Regulatory | Cisema Webinar

    “China DMF of API, Excipient & Packag...
  • pre-phase III drug clinical trial meeting guidelines

    Pre-phase III drug clinical trial meeting guidelines released

    Pre-phase III drug clinical trial meeting guide...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP